Table 1 Candidate variants in the discovery cohort.

From: Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

Gene

Variant description

Patient

Relevance

CHAD

NM_001267:c.1049C > T:p.(T350I)

PC-005;PC-015

PI3K-Akt pathway; present in individual with diagnosis before 40y; gene described in early-onset literature16

CHD1L

NM_004284:c.2398delT:p.(L800X)

PC-012

Loss-of-function variant; gene described in early-onset literature17

ERCC6

NM_000124:c.3437_3438insAAG:p.(S1146delinsRS)

PC-013

Nucleotide Excision Repair (NER); loss-of-function variant; gene described in early-onset literature18

ITGB7

NM_000889:c.1063_1066del:p.(V355fs)

PC-008

PI3K-Akt pathway; loss-of-function variant; gene described in early-onset literature16,19

PTPN13

NM_080685:c.4258 + 2 T > C

PC-008

Apoptosis; other gene family members have been described as potential candidates for CRC susceptibility16

SPATA20

NM_022827:c.151C > T:p.(R51X)

PC-015

Present in individual with diagnosis before 40y; loss-of-function variant; gene described in early-onset literature16,19

TDG

NM_003211:c.67C > T:p.(Q23X)

PC-018

Base Excision Repair (BER); loss-of-function variant; gene described in early-onset literature17

TGS1

NM_024831:c.439_444del:p.(147_148del)

PC-017

Peroxisome Proliferator-activated Receptors (PPAR) pathway; gene described in early-onset literature17

  1. Potential risk genes identified in the discovery cohort and selected for replication, with their corresponding detected rare, high-impact changes.